ASX - Delayed Quote AUD

IDT Australia Limited (IDT.AX)

Compare
0.0920
-0.0030
(-3.16%)
At close: 3:59:13 PM GMT+11
Loading Chart for IDT.AX
  • Previous Close 0.0950
  • Open 0.0950
  • Bid 0.0920 x --
  • Ask 0.0940 x --
  • Day's Range 0.0910 - 0.0950
  • 52 Week Range 0.0770 - 0.1450
  • Volume 106,904
  • Avg. Volume 289,674
  • Market Cap (intraday) 40.819M
  • Beta (5Y Monthly) 1.25
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 12, 2010
  • 1y Target Est --

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. It offers microbiological and analytical testing, clinical packaging, and pharmacy services. The company also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

en.idtaus.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: IDT.AX

View More

Performance Overview: IDT.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

IDT.AX
16.36%
S&P/ASX 200 [XJO] (^AXJO)
6.02%

1-Year Return

IDT.AX
12.20%
S&P/ASX 200 [XJO] (^AXJO)
1.91%

3-Year Return

IDT.AX
50.27%
S&P/ASX 200 [XJO] (^AXJO)
2.05%

5-Year Return

IDT.AX
12.38%
S&P/ASX 200 [XJO] (^AXJO)
51.31%

Compare To: IDT.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IDT.AX

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    39.53M

  • Enterprise Value

    42.77M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.00

  • Price/Book (mrq)

    1.48

  • Enterprise Value/Revenue

    2.42

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -25.58%

  • Return on Assets (ttm)

    -9.98%

  • Return on Equity (ttm)

    -19.31%

  • Revenue (ttm)

    18.77M

  • Net Income Avi to Common (ttm)

    -4.8M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.46M

  • Total Debt/Equity (mrq)

    17.62%

  • Levered Free Cash Flow (ttm)

    -9.49M

Research Analysis: IDT.AX

View More

Company Insights: IDT.AX

Research Reports: IDT.AX

View More

People Also Watch